The next generation of poxvirus-based vaccines: Current developments and advances

About this Research Topic

Background

In the last years mRNA- and adenovirus-based vaccine technologies have made great progress. Both approaches enable fast and effective vaccine development, which led to their approval for COVID-19. Accordingly, those technologies have attracted a lot of attention and have moved to the forefront of current vaccine research as the new state of the art. In contrast, poxvirus-based vaccines constituting another promising technology have been left behind and no such COVID-19 vaccine has entered phase III clinical trial testing.

Considering the huge potential of poxvirus-based vaccines and currently ongoing research with great prospects for improvements of this technology, we aim at featuring a collection of articles highlighting recent advances and thus emphasizing the importance of poxvirus-based vaccine research.

We hope this will help to generate renewed interest in this attractive topic.

This research topic will feature articles highlighting current developments, new ideas, strategies, and concepts in poxvirus-based vaccine research. The article collection shall comprise contributions from various fields (such as generation of vectors, genomic modification, regulation of transgene expression, expression of costimulatory factors as well as vaccine manufacturing and delivery systems) and deal with different types of poxviruses (such as vaccinia virus, fowl pox virus, parapoxvirus, canary poxvirus, and others). Another central aim is to engage in a critical assessment of the current state of the art, comparing the pros and cons of poxvirus-based vaccines with other available technologies as well as considering potential synergies. Ultimately, the main objective is to make the importance and potential of poxvirus-based vaccines evident to the reader in the context of current vaccine research and to provide researchers working in this field with an overview of current developments in order to support further improvements of this promising new technology.

• Original research on poxvirus-based vaccine technology including virus generation, genomic modification, regulation of transgene expression, and expression of costimulatory factors.
• Original research reporting on challenges and improvements in vaccine manufacturing and delivery systems concerned with poxviruses.
• Original research reporting on preclinical vaccine research concerned with characterizations of immune responses to poxvirus-based vaccines or reporting technical improvements.
• Original research reporting on early and advanced clinical trials using respective technologies for vaccine development independent of clinical indication.
• (Mini-) Review articles giving an overview of the current state of the art in the field with a view to technical improvements and translational research.
• Perspectives highlighting and discussing critical aspects or technical hurdles as well as future prospects in the field of poxvirus-based vaccine technology.


Dr.Flavia Chiuppesi is co-inventor on a patent application covering the development of a COVID-19 vaccine (PCT/US2021/032,821) using the synthetic MVA platform (sMVA). Dr.Flavia Chiuppesi's family member FW is a co-inventor on a patent application covering the design and construction of the synthetic MVA platform (PCT/US2021/016,247). Synthetic MVA-based COVID-19 vaccine COH04S1 has been licensed by GeoVax Inc.Ralf Amann is the inventor of several Orf Virus related patents which are licensed to Prime Vector
Technologies. Ralf Amann is a founding member and shareholder of Prime Vector Technologies. Prime Vector
Technologies aims to develop Orf Virus-based vaccines against infectious diseases and cancer for human
and veterinary applications. Markus W. Löffler reports personal fees from Boehringer Ingelheim for lectures/ consultancy and is listed as a co-inventor on several patents owned by Immatics Biotechnologies, concerning peptides for use in immunotherapies. The other coeditors declare no conflict of interests

Keywords: MVA, poxvirus, vaccinia virus, orf virus, viral vaccines, vaccines, armed vectors, heterologous prime boost, canarypox, fowlpox, attenuated vaccines, vaccine manufacturing, clinical trial, T cell response, antigen, transgene, humoral immunity

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

• What is a Research Topic?

  Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

  Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

• Why does Frontiers publish Research Topics? 

  The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

  Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

• Why are Research Topics important for journals?

  As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

  A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

• How do we ensure the quality of articles within Research Topics?

  Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

  In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

• What are the benefits of publishing my article in a Research Topic?

  Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

  As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

  Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

   
• What types of articles can be published in a Research Topic?

  Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

  Check available article types here 

• Can I suggest a new Research Topic? 

  Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

  Suggest your topic here 

• Who leads a Research Topic? 

  A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

  The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

• What is the role of a topic editor?

  As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

   

  You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

• What support will I receive when editing a new Research Topic? 

  As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

• As a junior researcher, can I be involved in editing a Research Topic? 

  If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

• Can I get a certificate for editing a Research Topic?

  Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

• Who will I collaborate with?

  Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

• How long does it take to publish a Research Topic?

  As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

  Find out more about our Research Topics

• What fee support is available to authors publishing in a Research Topic?

  Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

  Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

• Will there be a printed version of my Research Topic?

  In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.